Zestoretic and Abilify drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zestoretic (hydrochlorothiazide; lisinopril) and Abilify (aripiprazole). Common drug interactions include discomfort among females and dysarthria among males.

The phase IV clinical study analyzes what interactions people have when they take Zestoretic and Abilify. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Zestoretic?

Zestoretic has active ingredients of hydrochlorothiazide; lisinopril. It is often used in high blood pressure. eHealthMe is studying from 4,342 Zestoretic users. Check the latest studies of Zestoretic.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.



On Jul, 09, 2026

54 people who take Zestoretic and Abilify together, and have interactions are studied.

Zestoretic and Abilify drug interactions.

What are the common drug interactions of Zestoretic and Abilify, by gender? *:

female:

  1. Discomfort
  2. Drug dependence
  3. Drug hypersensitivity
  4. Ear infection
  5. Erythema (redness of the skin)
  6. Fall
  7. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  8. Haematocrit increased
  9. Haematoma (collection of blood outside the blood vessels)
  10. Haemoglobin increased

male:

  1. Dysarthria (speech disorder)
  2. Hypokalaemia (low potassium)
  3. Sexual dysfunction (difficulty experienced by an individual or a couple during any stage of a normal sexual activity)
  4. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  5. Agitation (state of anxiety or nervous excitement)
  6. Anuria (failure of the kidneys to produce urine)
  7. Asthenia (weakness)
  8. Blood creatinine increased
  9. Blood urea increased
  10. Drug ineffective

What are the common drug interactions of Zestoretic and Abilify, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Affective disorder (mental disorder)
  2. Anxiety
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Blood cholesterol increased
  5. Blood glucose increased
  6. Cholecystitis acute (rapid infection of gallbladder)
  7. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  8. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  9. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  10. Diabetes mellitus inadequate control

30-39:

n/a

40-49:

  1. Dysarthria (speech disorder)
  2. Hypokalaemia (low potassium)
  3. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  4. Asthenia (weakness)
  5. Headache (pain in head)
  6. Confusional state
  7. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  8. Anuria (failure of the kidneys to produce urine)
  9. White blood cell count increased
  10. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Agitation (state of anxiety or nervous excitement)
  3. Dysarthria (speech disorder)
  4. Hypokalaemia (low potassium)
  5. Initial insomnia (feeling of inadequate or poor-quality sleep)
  6. Insomnia (sleeplessness)
  7. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  8. Pain
  9. Speech disorder
  10. Abdominal discomfort

60+:

  1. Mixed liver injury
  2. Asthenia (weakness)
  3. Haemorrhage (bleeding)
  4. Left ventricular dysfunction
  5. Lipids increased (excess lipid in body)
  6. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
  7. Type 2 diabetes mellitus
  8. Weight increased
  9. Blood creatinine increased
  10. Blood urea increased

What are the existing conditions these people have? *

  1. Menopausal Symptoms: 15 people, 27.78%
  2. Bipolar Disorder (mood disorder): 14 people, 25.93%
  3. Insomnia (sleeplessness): 11 people, 20.37%
  4. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 10 people, 18.52%
  5. Post-Traumatic Stress Disorder: 10 people, 18.52%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 9 people, 16.67%
  7. Seasonal Allergy (allergic condition due to certain season): 8 people, 14.81%
  8. High Blood Cholesterol: 4 people, 7.41%
  9. Hot Flush (sudden feelings of heat): 4 people, 7.41%
  10. Stress And Anxiety: 4 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Zestoretic and Abilify?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zestoretic and Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zestoretic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zestoretic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Abilify and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydrochlorothiazide; lisinopril and aripiprazole (the active ingredients of Zestoretic and Abilify, respectively), and Zestoretic and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: